Results Induction of p70S6K1 phosphorylation by IGF-1R inhibitor is independent of K-Ras and PIK3CA mutations Previously, we demonstrated that treatment of HCT116 and SW480 cells with an IGF-1R inhibitor, OSI-906, increases phosphorylation of p70S6K1
Future studies with specific outcomes, larger sample sizes, different ages, taking into consideration baseline glutathione levels, are needed to better assess treatment outcomes
In contrast, short-term administration exhibits no marked distribution, implying that the beneficial effects of quercetin in preventing lung respiratory viral infection could be maximized by long-term administration
If you compare a 12,00018,000 medical-grade glow IV drip to a 5,000 basic glutathione push at a wellness lounge, the difference is not just price it is formulation depth, ingredient quality, clinical supervision, and results